Application of CellSearch technique in detection of peripheral blood circulating tumour cell count in patients with head and neck cancer and its association with prognosis

Li,Haiyang; Li,Pingdong; Li,Feng; Wang,Tao

doi:10.3892/ol.2024.14846

Application of CellSearch technique in detection of peripheral blood circulating tumour cell count in patients with head and neck cancer and its association with prognosis

Authors:
- Haiyang Li
- Pingdong Li
- Feng Li
- Tao Wang
View Affiliations

Affiliations: Department of Otolaryngology, Beijing Daxing District People's Hospital, Beijing 102600, P.R. China, Department of Otolaryngology, Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, P.R. China
Published online on: December 13, 2024 https://doi.org/10.3892/ol.2024.14846
Article Number: 100
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to employ CELLSEARCH® technology for the detection of circulating tumor cells (CTCs) in the peripheral blood of head and neck cancer (HNC) patients, and to assess the association between CTC count and patient prognosis. In this retrospective study, a cohort of 56 patients diagnosed with HNC and receiving treatment at the Department of Otolaryngology, Head and Neck Surgery (Beijing Tongren Hospital) between December 2013 and June 2018 were selected. Utilizing CELLSEARCH® technology, the presence of CTCs were detected in samples of peripheral blood from patients with head and neck cancer (HNC) patients, and CTC counts were documented. CTC positivity was defined as CTCs ≥1/7.5 ml of peripheral blood. Comprehensive data encompassing general demographic profiles, pathological classifications, tumor node metastasis (TNM) staging, tumor histology and treatment modalities were gathered for each participant. The study employed the Kaplan‑Meier method to scrutinize and compare survival rates between CTC‑positive and CTC‑negative cohorts, while both univariate and multivariate Cox regression analyses were conducted to discern the factors impacting the overall survival (OS) of individuals diagnosed with HNC. Out of the 56 patients examined, 14 individuals exhibited detectable levels of CTCs, resulting in a positivity rate of 25%. The analysis revealed a significant association between the levels of CTCs in patients with HNC and the utilization of non‑surgical treatment (P<0.05), while no substantial associations were observed concerning sex, age, smoking habits, alcohol consumption, pathological classifications, TNM staging, tumor attributes and surgical interventions (all P>0.05). Survival analysis revealed a reduction in the OS among patients with HNC harboring CTC positivity in contrast to their CTC‑negative counterparts. The comprehensive multivariate Cox regression analysis underscored the independent prognostic impact of CTC presence (HR=1.274; 95% CI, 1.119‑1.451; P<0.001) and the implementation of non‑surgical treatment (HR=0.268; 95% CI, 0.119‑0.607; P=0.002) on the prognosis of individuals grappling with HNC. In conclusion, the levels of CTCs were an independent factor affecting outcomes in patients with HNC, with CTC‑positive patients showing significantly shorter survival compared with CTC‑negative cases.

View Figures

View References

1	Mody MD, Rocco JW, Yom SS, Haddad RI and Saba NF: Head and neck cancer. Lancet. 398:2289–2299. 2021. View Article : Google Scholar : PubMed/NCBI
2	Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE and Grandis JR: Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 6:922020. View Article : Google Scholar : PubMed/NCBI
3	Di Credico G, Polesel J, Dal Maso L, Pauli F, Torelli N, Luce D, Radoï L, Matsuo K, Serraino D, Brennan P, et al: Alcohol drinking and head and neck cancer risk: The joint effect of intensity and duration. Br J Cancer. 123:1456–1463. 2020. View Article : Google Scholar : PubMed/NCBI
4	Gupta I, Ghabreau L, Al-Thawadi H, Yasmeen A, Vranic S, Al Moustafa AE and Malki MI: Co-incidence of human papillomaviruses and Epstein-barr virus is associated with high to intermediate tumor grade in human head and neck cancer in syria. Front Oncol. 10:10162020. View Article : Google Scholar : PubMed/NCBI
5	Mourad M, Jetmore T, Jategaonkar AA, Moubayed S, Moshier E and Urken ML: Epidemiological trends of head and neck cancer in the united states: A SEER population study. J Oral Maxillofac Surg. 75:2562–2572. 2017. View Article : Google Scholar : PubMed/NCBI
6	Economopoulou P, Kotsantis I, Kyrodimos E, Lianidou ES and Psyrri A: Liquid biopsy: An emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs). Oral Oncol. 74:83–89. 2017. View Article : Google Scholar : PubMed/NCBI
7	Takes RP, Rinaldo A, Silver CE, Haigentz M Jr, Woolgar JA, Triantafyllou A, Mondin V, Paccagnella D, de Bree R, Shaha AR, et al: Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects. Oral Oncol. 48:775–779. 2012. View Article : Google Scholar : PubMed/NCBI
8	Kopczyński P and Flieger R: Tumor markers used in the diagnosis, monitoring, treatment, and prognosis head and neck cancer. Pol Merkur Lekarski. 35:37–38. 2013.(In Polish). PubMed/NCBI
9	Eskander A, Irish J, Groome PA, Freeman J, Gullane P, Gilbert R, Hall SF, Urbach DR and Goldstein DP: Volume-outcome relationships for head and neck cancer surgery in a universal health care system. Laryngoscope. 124:2081–2088. 2014. View Article : Google Scholar : PubMed/NCBI
10	Leipzig B, Zellmer JE and Klug D: The role of endoscopy in evaluating patients with head and neck cancer. A multi-institutional prospective study. Arch Otolaryngol. 111:589–594. 1985. View Article : Google Scholar : PubMed/NCBI
11	Chung CS, Lo WC, Wen MH, Hsieh CH, Lin YC and Liao LJ: Long term outcome of routine Image-enhanced endoscopy in newly diagnosed head and neck cancer: A prospective study of 145 patients. Sci Rep. 6:295732016. View Article : Google Scholar : PubMed/NCBI
12	Pantel K and Speicher MR: The biology of circulating tumor cells. Oncogene. 35:1216–1224. 2016. View Article : Google Scholar : PubMed/NCBI
13	Novel Biomarkers in the Continuum of Breast Cancer. Anticancer Res. 36:32242016.
14	Shen Z, Wu A and Chen X: Current detection technologies for circulating tumor cells. Chem Soci Rev. 46:2038–2056. 2017. View Article : Google Scholar
15	Bidard FC, Proudhon C and Pierga JY: Circulating tumor cells in breast cancer. Mol Oncol. 10:418–430. 2016. View Article : Google Scholar : PubMed/NCBI
16	Pantel K, Hille C and Scher HI: Circulating tumor cells in prostate cancer: From discovery to clinical utility. Clin Chem. 65:87–99. 2019. View Article : Google Scholar : PubMed/NCBI
17	Jia S, Zhang R, Li Z and Li J: Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer. Oncotarget. 8:55632–55645. 2017. View Article : Google Scholar : PubMed/NCBI
18	Tong M, Luo S, Gu L, Wang X, Zhang Z, Liang C, Huang H, Lin Y and Huang J: SIMarker: Cellular similarity detection and its application to diagnosis and prognosis of liver cancer. Comput Biol Med. 171:1081132024. View Article : Google Scholar : PubMed/NCBI
19	Ramirez JM, Fehm T, Orsini M, Cayrefourcq L, Maudelonde T, Pantel K and Alix-Panabières C: Prognostic relevance of viable circulating tumor cells detected by EPISPOT in metastatic breast cancer patients. Clin Chem. 60:214–221. 2014. View Article : Google Scholar : PubMed/NCBI
20	Lin D, Shen L, Luo M, Zhang K, Li J, Yang Q, Zhu F, Zhou D, Zheng S, Chen Y and Zhou J: Circulating tumor cells: Biology and clinical significance. Signal Transduct Target Ther. 6:4042021. View Article : Google Scholar : PubMed/NCBI
21	Coumans F and Terstappen L: Detection and characterization of circulating tumor cells by the cellsearch approach. Methods Mol Biol. 1347:263–278. 2015. View Article : Google Scholar : PubMed/NCBI
22	Rheinländer A, Schraven B and Bommhardt U: CD45 in human physiology and clinical medicine. Immunol Lett. 196:22–32. 2018. View Article : Google Scholar : PubMed/NCBI
23	Alix-Panabières C and Pantel K: Challenges in circulating tumour cell research. Nat Rev Cancer. 14:623–631. 2014. View Article : Google Scholar : PubMed/NCBI
24	Alix-Panabières C and Pantel K: Circulating tumor cells: Liquid biopsy of cancer. Clin Chem. 59:110–118. 2013. View Article : Google Scholar : PubMed/NCBI
25	Deng Z, Wu S, Wang Y and Shi D: Circulating tumor cell isolation for cancer diagnosis and prognosis. EBioMedicine. 83:1042372022. View Article : Google Scholar : PubMed/NCBI
26	Pereira-Veiga T, Schneegans S, Pantel K and Wikman H: Circulating tumor cell-blood cell crosstalk: Biology and clinical relevance. Cell Rep. 40:1112982022. View Article : Google Scholar : PubMed/NCBI
27	Yu M, Stott S, Toner M, Maheswaran S and Haber DA: Circulating tumor cells: Approaches to isolation and characterization. J Cell Biol. 192:373–382. 2011. View Article : Google Scholar : PubMed/NCBI
28	Park CH, Lee JI, Sung J, Choi S and Ko KP: A flow visualization model of duodenogastric reflux after esophagectomy with gastric interposition. J Cardiothorac Surg. 8:1922013. View Article : Google Scholar : PubMed/NCBI
29	Zhang Z, Xiao Y, Zhao J, Chen M, Xu Y, Zhong W, Xing J and Wang M: Relationship between circulating tumour cell count and prognosis following chemotherapy in patients with advanced non-small-cell lung cancer. Respirology. 21:519–525. 2016. View Article : Google Scholar : PubMed/NCBI
30	Nieva J, Wendel M, Luttgen MS, Marrinucci D, Bazhenova L, Kolatkar A, Santala R, Whittenberger B, Burke J, Torrey M, et al: High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: A longitudinal analysis. Phys Biol. 9:0160042012. View Article : Google Scholar : PubMed/NCBI
31	Nichols AC, Lowes LE, Szeto CC, Basmaji J, Dhaliwal S, Chapeskie C, Todorovic B, Read N, Venkatesan V, Hammond A, et al: Detection of circulating tumor cells in advanced head and neck cancer using the CellSearch system. Head Neck. 34:1440–1444. 2012. View Article : Google Scholar : PubMed/NCBI
32	Bozec A, Ilie M, Dassonville O, Long E, Poissonnet G, Santini J, Chamorey E, Ettaiche M, Chauvière D, Peyrade F, et al: Significance of circulating tumor cell detection using the CellSearch system in patients with locally advanced head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 270:2745–2749. 2013. View Article : Google Scholar : PubMed/NCBI
33	Buglione M, Grisanti S, Almici C, Mangoni M, Polli C, Consoli F, Verardi R, Costa L, Paiar F, Pasinetti N, et al: Circulating tumour cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. Eur J Cancer. 48:3019–3026. 2012. View Article : Google Scholar : PubMed/NCBI
34	Guney K, Yoldas B, Ozbilim G, Derin AT, Sarihan S and Balkan E: Detection of micrometastatic tumor cells in head and neck squamous cell carcinoma. A possible predictor of recurrences? Saudi Med J. 28:216–220. 2007.PubMed/NCBI
35	Li H, Li B, Pan Y, Zhang Y, Xiang J, Zhang Y, Sun Y, Yu X, He W and Hu H: Preoperative folate receptor-positive circulating tumor cell level is a prognostic factor of long term outcome in non-small cell lung cancer patients. Front Oncol. 10:6214352020. View Article : Google Scholar : PubMed/NCBI
36	Bertamini L and Oliva S: High levels of circulating tumor plasma cells as a key hallmark of aggressive disease in Transplant-Eligible patients with newly diagnosed multiple myeloma. J Clin Oncol. 40:3120–3131. 2022. View Article : Google Scholar : PubMed/NCBI
37	Ju L, Yang J, Zhai C, Chai S, Dong Z and Li M: Survival, Chemotherapy and Chemosensitivity Predicted by CTC Cultured In Vitro of SCLC Patients. Front Oncol. 11:6833182021. View Article : Google Scholar : PubMed/NCBI
38	Martin OA, Anderson RL, Russell PA, Cox RA, Ivashkevich A, Swierczak A, Doherty JP, Jacobs DH, Smith J, Siva S, et al: Mobilization of viable tumor cells into the circulation during radiation therapy. Int J Radiat Oncol Biol Phys. 88:395–403. 2014. View Article : Google Scholar : PubMed/NCBI
39	Morosin T, Ashford B, Ranson M, Gupta R, Clark J, Iyer NG and Spring K: Circulating tumour cells in regionally metastatic cutaneous squamous cell carcinoma: A pilot study. Oncotarget. 7:47111–47115. 2016. View Article : Google Scholar : PubMed/NCBI
40	Balasubramanian P, Lang JC, Jatana KR, Miller B, Ozer E, Old M, Schuller DE, Agrawal A, Teknos TN, Summers TA Jr, et al: Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck. PLoS One. 7:e420482012. View Article : Google Scholar : PubMed/NCBI
41	Dorsey JF, Kao GD, MacArthur KM, Ju M, Steinmetz D, Wileyto EP, Simone CB II and Hahn SM: Tracking viable circulating tumor cells (CTCs) in the peripheral blood of non-small cell lung cancer (NSCLC) patients undergoing definitive radiation therapy: Pilot study results. Cancer. 121:139–149. 2015. View Article : Google Scholar : PubMed/NCBI
42	Jatana KR, Balasubramanian P, Lang JC, Yang L, Jatana CA, White E, Agrawal A, Ozer E, Schuller DE, Teknos TN and Chalmers JJ: Significance of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: Initial results. Arch Otolaryngol Head Neck Surg. 136:1274–1279. 2010. View Article : Google Scholar : PubMed/NCBI
43	Winter SC, Stephenson SA, Subramaniam SK, Paleri V, Ha K, Marnane C, Krishnan S and Rees G: Long term survival following the detection of circulating tumour cells in head and neck squamous cell carcinoma. BMC Cancer. 9:4242009. View Article : Google Scholar : PubMed/NCBI
44	Jatana KR, Balasubramanian P, McMullen KP, Lang JC, Teknos TN and Chalmers JJ: Effect of surgical intervention on circulating tumor cells in patients with squamous cell carcinoma of the head and neck using a negative enrichment technology. Head Neck. 38:1799–1803. 2016. View Article : Google Scholar : PubMed/NCBI
45	Gao W, Li JZ, Ho WK, Chan JY and Wong TS: Biomarkers for use in monitoring responses of nasopharyngeal carcinoma cells to ionizing radiation. Sensors (Basel). 12:8832–8846. 2012. View Article : Google Scholar : PubMed/NCBI
46	Tinhofer I, Hristozova T, Stromberger C, Keilhoiz U and Budach V: Monitoring of circulating tumor cells and their expression of EGFR/phospho-EGFR during combined radiotherapy regimens in locally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 83:e685–e690. 2012. View Article : Google Scholar : PubMed/NCBI
47	Jatana KR, Lang JC and Chalmers JJ: Identification of circulating tumor cells: A prognostic marker in squamous cell carcinoma of the head and neck? Future Oncol. 7:481–484. 2011. View Article : Google Scholar : PubMed/NCBI
48	Schochter F, Friedl TWP, deGregorio A, Krause S, Huober J, Rack B and Janni W: Are Circulating tumor cells (CTCs) ready for clinical use in breast cancer? An overview of completed and ongoing trials using CTCs for clinical treatment decisions. Cells. 8:14122019. View Article : Google Scholar : PubMed/NCBI
49	Kyrodimos E, Chrysovergis A, Mastronikolis N, Tsiambas E, Ragos V, Roukas D, Fotiades P and Papanikolaou V: Targeting EGFR in nasopharyngeal carcinoma. J BUON. 26:759–761. 2021.PubMed/NCBI
50	Aguayo F, Perez-Dominguez F and Osorio JC: PI3K/AKT/mTOR signaling pathway in HPV-Driven head and neck carcinogenesis: Therapeutic implications. Biology (Basel). 12:6722023.PubMed/NCBI
51	O'Meara CH and Jafri Z: Immune checkpoint inhibitors, Small-molecule immunotherapies and the emerging role of neutrophil extracellular traps in therapeutic strategies for head and neck cancer. Int J Mol Sci. 24:116952023. View Article : Google Scholar : PubMed/NCBI
52	Bao Y, Gabrielpillai J, Dietrich J, Zarbl R, Strieth S, Schröck F and Dietrich D: Fibroblast growth factor (FGF), FGF receptor (FGFR), and cyclin D1 (CCND1) DNA methylation in head and neck squamous cell carcinomas is associated with transcriptional activity, gene amplification, human papillomavirus (HPV) status, and sensitivity to tyrosine kinase inhibitors. Clin Epigenetics. 13:2282021. View Article : Google Scholar : PubMed/NCBI
53	Khadela A, Shah Y, Mistry P, Mansuri M, Sureja D and Bodiwala K: A review of efficacy and safety of cetuximab and bevacizumab-based monoclonal antibodies in head and neck cancer. Med Oncol. 40:662022. View Article : Google Scholar : PubMed/NCBI
54	Cierpikowski P, Leszczyszyn A and Bar J: The role of hedgehog signaling pathway in head and neck squamous cell carcinoma. Cells. 12:20832023. View Article : Google Scholar : PubMed/NCBI
55	Tsimberidou AM, Fountzilas E, Nikanjam M and Kurzrock R: Review of precision cancer medicine: Evolution of the treatment paradigm. Cancer Treat Rev. 86:1020192020. View Article : Google Scholar : PubMed/NCBI
56	de Wit S, van Dalum G and Terstappen LW: Detection of circulating tumor cells. Scientifica (Cairo). 2014:8193622014.PubMed/NCBI
57	Hoeppener AE, Swennenhuis JF and Terstappen LW: Immunomagnetic separation technologies. Recent Results Cancer Res. 195:43–58. 2012. View Article : Google Scholar : PubMed/NCBI
58	Hanna GJ, Patel N, Tedla SG, Baugnon KL, Aiken A and Agrawal N: Personalizing surveillance in head and neck cancer. Am Soc Clin Oncol Educ Book. 43:e3897182023. View Article : Google Scholar : PubMed/NCBI
59	Huang X, Duijf PHG, Sriram S, Perera G, Vasani S, Kenny L, Leo P and Punyadeera C: Circulating tumour DNA alterations: Emerging biomarker in head and neck squamous cell carcinoma. J Biomed Sci. 30:652023. View Article : Google Scholar : PubMed/NCBI
60	Tsutsuyama M and Nakanishi H: Detection of circulating tumor cells in drainage venous blood from colorectal cancer patients using a new filtration and cytology-based automated platform. PLoS One. 14:e02122212019. View Article : Google Scholar : PubMed/NCBI